• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠肺动脉循环中的磷酸二酯酶同工型:肺动脉高压中的变化

Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension.

作者信息

Maclean M R, Johnston E D, Mcculloch K M, Pooley L, Houslay M D, Sweeney G

机构信息

Division of Neuroscience and Biomedical Systems, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, Scotland.

出版信息

J Pharmacol Exp Ther. 1997 Nov;283(2):619-24.

PMID:9353377
Abstract

Phosphodiesterase (PDE) activity was determined in pulmonary arteries removed from control and chronic hypoxia-induced pulmonary hypertensive rats. The main, first-branch, intrapulmonary and resistance pulmonary arteries were studied. We measured total cAMP PDE activity and cGMP PDE activity, as well as that of individual isoforms (PDE1-5). cAMP PDE activity in chronic hypoxic rats was increased in first-branch and intrapulmonary arteries from hypoxic rats. No changes were observed in the main or resistance pulmonary arteries. Similarly, cGMP PDE activity was increased in the main, first-branch and intra-pulmonary arteries of the hypoxic rats. No changes in cGMP PDE activity were observed in resistance arteries. There was evidence for PDE1-5 activity in all pulmonary arteries. The increased cAMP PDE activity in first-branch and intrapulmonary vessels was associated with an increase in cilostimide-inhibited PDE (PDE3) activity. Increased total cGMP PDE in main pulmonary artery was associated with increases in Ca++/calmodulin-stimulated (PDE1) activity. An increase in zaprinast-inhibited (PDE5) activity was observed in first-branch and intrapulmonary arteries. Our results suggest that decreases in intracellular cyclic nucleotide levels in pulmonary arteries from pulmonary hypertensive rats are associated with increased PDE activity. Further, these changes may reflect alterations at the level of specific types of PDE isoforms.

摘要

在从对照大鼠和慢性低氧诱导的肺动脉高压大鼠中取出的肺动脉中测定磷酸二酯酶(PDE)活性。研究了主肺动脉、第一分支肺动脉、肺内动脉和阻力肺动脉。我们测量了总cAMP PDE活性、cGMP PDE活性以及各个同工型(PDE1 - 5)的活性。慢性低氧大鼠第一分支肺动脉和肺内动脉中的cAMP PDE活性增加。主肺动脉或阻力肺动脉中未观察到变化。同样,低氧大鼠的主肺动脉、第一分支肺动脉和肺内动脉中的cGMP PDE活性增加。阻力动脉中未观察到cGMP PDE活性变化。所有肺动脉中均有PDE1 - 5活性的证据。第一分支血管和肺内血管中cAMP PDE活性的增加与西洛司特抑制的PDE(PDE3)活性增加有关。主肺动脉中总cGMP PDE的增加与Ca++/钙调蛋白刺激的(PDE1)活性增加有关。在第一分支肺动脉和肺内动脉中观察到扎普司特抑制的(PDE5)活性增加。我们的结果表明,肺动脉高压大鼠肺动脉中细胞内环核苷酸水平的降低与PDE活性增加有关。此外,这些变化可能反映了特定类型的PDE同工型水平的改变。

相似文献

1
Phosphodiesterase isoforms in the pulmonary arterial circulation of the rat: changes in pulmonary hypertension.大鼠肺动脉循环中的磷酸二酯酶同工型:肺动脉高压中的变化
J Pharmacol Exp Ther. 1997 Nov;283(2):619-24.
2
Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.在肺动脉高压模型中,环磷酸鸟苷(cGMP)抑制的环磷酸腺苷(cAMP)特异性磷酸二酯酶(PDE3)和环磷酸鸟苷结合的环磷酸鸟苷特异性磷酸二酯酶(PDE5)表达增加。
Br J Pharmacol. 2002 Dec;137(8):1187-94. doi: 10.1038/sj.bjp.0704984.
3
Phosphodiesterase activity in intrapulmonary arteries and veins of perinatal lambs.围产期羔羊肺内动脉和静脉中的磷酸二酯酶活性。
Mol Genet Metab. 1998 Nov;65(3):229-37. doi: 10.1006/mgme.1998.2756.
4
Immunohistochemical distribution of cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human vagina: a potential forensic value?环核苷酸磷酸二酯酶(PDE)同工酶在人阴道中的免疫组织化学分布:具有潜在法医价值?
J Forensic Leg Med. 2007 Jul;14(5):270-4. doi: 10.1016/j.jcfm.2006.08.010. Epub 2006 Nov 20.
5
Preliminary identification and role of phosphodiesterase isozymes in human basophils.磷酸二酯酶同工酶在人嗜碱性粒细胞中的初步鉴定及其作用
J Immunol. 1992 Apr 15;148(8):2503-10.
6
Characterisation of cyclic nucleotide phosphodiesterase isoforms in the media layer of the main pulmonary artery.主肺动脉中层中环状核苷酸磷酸二酯酶同工型的表征
Biochem Pharmacol. 2002 May 1;63(9):1763-72. doi: 10.1016/s0006-2952(02)00919-x.
7
The role of phosphodiesterase isoforms 2, 5, and 9 in the regulation of NO-dependent and NO-independent cGMP production in the rat cervical spinal cord.磷酸二酯酶同工型2、5和9在大鼠颈脊髓中一氧化氮依赖性和非一氧化氮依赖性环鸟苷酸生成调节中的作用
J Chem Neuroanat. 2006 Jun;31(4):275-303. doi: 10.1016/j.jchemneu.2006.02.006. Epub 2006 Apr 18.
8
PDE4 and PDE5 regulate cyclic nucleotides relaxing effects in human umbilical arteries.磷酸二酯酶4和磷酸二酯酶5调节环核苷酸对人脐动脉的舒张作用。
Eur J Pharmacol. 2008 Mar 17;582(1-3):102-9. doi: 10.1016/j.ejphar.2007.12.017. Epub 2007 Dec 28.
9
Potentiation of erectile response and cAMP accumulation by combination of prostaglandin E1 and rolipram, a selective inhibitor of the type 4 phosphodiesterase (PDE 4).前列腺素E1与4型磷酸二酯酶(PDE 4)的选择性抑制剂咯利普兰联合使用对勃起反应和环磷酸腺苷(cAMP)积累的增强作用。
J Urol. 1999 Nov;162(5):1848-55.
10
Phosphodiesterase inhibition by a gastroprotective agent irsogladine: preferential blockade of cAMP hydrolysis.胃保护剂伊索前列定对磷酸二酯酶的抑制作用:对环磷酸腺苷(cAMP)水解的优先阻断
Life Sci. 2004 Aug 27;75(15):1833-42. doi: 10.1016/j.lfs.2004.03.022.

引用本文的文献

1
Comparison of cilomilast, tadalafil, and both drug combinations in the treatment of monocrotaline-induced pulmonary arterial hypertension in rats.西洛司特、他达拉非及二者联合用药治疗大鼠野百合碱诱导的肺动脉高压的比较。
BMC Cardiovasc Disord. 2025 Aug 9;25(1):591. doi: 10.1186/s12872-025-05065-0.
2
Phosphodiesterase in heart and vessels: from physiology to diseases.心脏和血管中的磷酸二酯酶:从生理学到疾病。
Physiol Rev. 2024 Apr 1;104(2):765-834. doi: 10.1152/physrev.00015.2023. Epub 2023 Nov 16.
3
Pathogenic Mechanisms of Pulmonary Arterial Hypertension: Homeostasis Imbalance of Endothelium-Derived Relaxing and Contracting Factors.
肺动脉高压的发病机制:内皮源性舒张因子与收缩因子的稳态失衡
JACC Asia. 2022 Dec 15;2(7):787-802. doi: 10.1016/j.jacasi.2022.09.010. eCollection 2022 Dec.
4
Sildenafil 4.0-Integrated Synthetic Chemistry, Formulation and Analytical Strategies Effecting Immense Therapeutic and Societal Impact in the Fourth Industrial Era.西地那非4.0——综合合成化学、制剂与分析策略,在第四次工业时代产生巨大治疗与社会影响。
Pharmaceuticals (Basel). 2021 Apr 15;14(4):365. doi: 10.3390/ph14040365.
5
Role of phosphodiesterase 1 in the pathophysiology of diseases and potential therapeutic opportunities.磷酸二酯酶 1 在疾病病理生理学中的作用及潜在治疗机会。
Pharmacol Ther. 2021 Oct;226:107858. doi: 10.1016/j.pharmthera.2021.107858. Epub 2021 Apr 22.
6
A current view of G protein-coupled receptor - mediated signaling in pulmonary hypertension: finding opportunities for therapeutic intervention.肺动脉高压中G蛋白偶联受体介导信号传导的当前观点:寻找治疗干预机会
Vessel Plus. 2018;2. doi: 10.20517/2574-1209.2018.44. Epub 2018 Aug 30.
7
GPCRs in pulmonary arterial hypertension: tipping the balance.肺动脉高压中的 G 蛋白偶联受体:打破平衡。
Br J Pharmacol. 2018 Aug;175(15):3063-3079. doi: 10.1111/bph.14172. Epub 2018 Apr 17.
8
Effects of Single Drug and Combined Short-term Administration of Sildenafil, Pimobendan, and Nicorandil on Right Ventricular Function in Rats With Monocrotaline-induced Pulmonary Hypertension.西地那非、匹莫苯丹和尼可地尔单药及联合短期给药对野百合碱诱导的肺动脉高压大鼠右心室功能的影响。
J Cardiovasc Pharmacol. 2015 Jun;65(6):640-8. doi: 10.1097/FJC.0000000000000236.
9
The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseases.磷酸二酯酶抑制剂在肺血管疾病管理中的作用。
Glob Cardiol Sci Pract. 2014 Oct 16;2014(3):257-90. doi: 10.5339/gcsp.2014.42. eCollection 2014.
10
Revisiting cAMP signaling in the carotid body.重新审视颈动脉体中的 cAMP 信号转导。
Front Physiol. 2014 Oct 28;5:406. doi: 10.3389/fphys.2014.00406. eCollection 2014.